HABER INC

HABER INC, a veteran in Laboratory Analytical Instruments (SIC 3826), builds precision diagnostics systems that enable pharmaceutical, environmental, and industrial researchers to parse complex chemical signatures with confidence; its flagship chromatography platforms and custom sensor suites equip GMP labs and regulatory bodies with data integrity, while service teams support installation, calibration, and compliance tracking. The company’s core offering lies in ruggedized analytical instruments paired with software that streamlines data acquisition for target customers ranging from biotech innovators to municipal water authorities, all of whom face accelerating demands for throughput and traceability. Regulatory oversight under the SEC and FDA means material risks include rapid technological change, supply chain disruptions for specialized components, and the need to continually validate methodologies within stringent quality systems, as underscored by HABER’s latest Form 10-K filed December 1999, which details those compliance pressures alongside capital intensity in instrumentation development. For up-to-date disclosures, view live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025